Paediatric Hematologic Research Group

61 – 70 of 122

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000535?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
6
7
8
9
…
13
next »

2008
Mark Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
Tedgård, Ulf ^LU ; Ljung, Rolf ^LU ; Bullinger, M and Von Mackensen, S (2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150
- Contribution to journal › Published meeting abstract
Mark Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
Fischer, K ; Valentino, L ; Ljung, Rolf ^LU and Blanchette, V (2008) In Haemophilia 14(s3). p.196-201
- Contribution to journal › Article
Mark Being a carrier of haemophilia - how does it influence quality of life?
Tedgård, Ulf ^LU and Von Mackensen, S (2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.152-153
- Contribution to journal › Published meeting abstract
Mark Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
Knobe, Karin ^LU ; Sjörin, Elsy ^LU and Ljung, Rolf ^LU (2008) In Haemophilia May 4. p.723-728
- Contribution to journal › Article
2007
Mark The risk associated with indwelling catheters in children with haemophilia.
Ljung, Rolf ^LU (2007) In British Journal of Haematology 138(5). p.580-586
- Contribution to journal › Scientific review
Mark Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
Ljung, Rolf ^LU (2007) In Haemophilia 13(s2). p.1-3
- Contribution to journal › Debate/Note/Editorial
Mark Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
Gouw, Samantha C. ; van der Bom, Johanna G. ; Auerswald, Guenter ; Ettinghausen, Carmen Escuriola ; Tedgård, Ulf ^LU and van den Berg, H. Marijke (2007) In Blood 109(11). p.4693-4697
- Contribution to journal › Article
Mark The thalassaemia syndromes
Birgens, Henrik and Ljung, Rolf ^LU (2007) In Scandinavian Journal of Clinical & Laboratory Investigation 67(1). p.41603-41603
- Contribution to journal › Scientific review
Mark Gadolinium Contrast Agent is of Limited Value for Magnetic Resonance Imaging Assessment of Synovial Hypertrophy in Hemophiliacs.
Lundin, Björn ^LU ; Berntorp, Erik ^LU ; Pettersson, Holger ^LU ; Wirestam, Ronnie ^LU ; Jonsson, K ; Ståhlberg, Freddy ^LU and Ljung, Rolf ^LU (2007) In Acta Radiologica 48(5). p.520-530
- Contribution to journal › Article
2006
Mark Are randomized clinical trials the only truth? Not always
Aledort, L ; Ljung, Rolf ^LU and Blanchette, V (2006) In Journal of Thrombosis and Haemostasis 4(3). p.503-504
- Contribution to journal › Debate/Note/Editorial

« previous
1
…
6
7
8
9
…
13
next »